Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Gibiansky
Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma and Exposure–Response in CLL
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
Related publications
DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)
Science-Business eXchange
Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).
International Journal of Advanced Research
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Bendamustine (B), Followed by Obinutuzumab (G) and Venetoclax (A) in Patients With Chronic Lymphocytic Leukemia (Cll): Cll2-Bag Trial of the German CLL Study Group (Gcllsg)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Venetoclax–Obinutuzumab Elicits High Response Rates in CLL
Cancer Discovery
Oncology
The PI3Kδ INHIBITOR ME-401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Health Economics and Outcomes Data Requirements in Indolent Non Hodgkins Lymphoma (Inhl) and Chronic Lymphocytic Leukemia (Cll) From United States Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Mp12: Cryoglobulinemia in a Patient With Chronic Lymphocytic Leukemia (Cll)– A Case Report and Review of Literature of Renal Involvement in CLL
Journal of Investigative Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
